Back to User profile » Dr Weilan Wang
Paper published by Dr Weilan Wang:
Original Research
Risk of bleeding associated with antiangiogenic monoclonal antibodies bevacizumab and ramucirumab: a meta-analysis of 85 randomized controlled trials
Xiao B, Wang W, Zhang D
OncoTargets and Therapy 2018, 11:5059-5074
Published Date: 21 August 2018